HCA — HCA Healthcare, Inc. stock price, charts and financials

QT50HCA Healthcare, Inc.

HCA Healthcare, Inc. (NYSE: HCA) is a Healthcare company in the Medical - Care Facilities industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
406.61
+4.02+1.00%
HCAQT50HCA Healthcare, Inc.·NYSE
406.61+1.00%
TA
Loading chart...
Screen all →
Snapshot
IndexS&P 500P/E13.44EPS (ttm)29.96Insider Own-Shs Outstand216.50MPerf Week5.34%
Market Cap87.16BForward P/E12.48EPS next Y32.25Insider Trans-0.03%Shs Float146.40MPerf Month2.38%
Enterprise Value134.92BPEG0.55EPS next Q7.10Inst Own-Short Float3.98%Perf Quarter-7.33%
Income6.64BP/S1.12EPS this Y1.70%Inst Trans-Short Ratio3.66Perf Half Y-16.57%
Sales78.01BP/B-EPS next Y9.06%ROA11.30%Short Interest5.83MPerf YTD-13.77%
Book/sh-P/C8.06EPS next 5Y10.95%ROE-112.87%52W High562.08 -27.66%Perf Year13.39%
Cash/sh-P/FCF14.53EPS past 3/5Y14.01% 21.03%ROIC19.41%52W Low356.64 14.01%Perf 3Y42.67%
Dividend Est.3.12 (0.77%)EV/EBITDA8.52Sales past 3/5Y7.87% 7.97%Gross Margin28.36%Volatility3.86% 3.56%Perf 5Y62.03%
Dividend TTM3.00 (0.74%)EV/Sales1.73EPS Y/Y TTM32.18%Oper. Margin15.48%ATR (14)14.15Perf 10Y399.31%
Dividend Ex-DateSep 16, 2026Quick Ratio0.69Sales Y/Y TTM8.19%Profit Margin8.77%RSI (14)54.60Recom2.41
Dividend Gr. 3/5Y8.74% 46.28%Current Ratio0.78EPS Q/Q10.96%SMA202.64%Beta1.09Target Price460.18
Payout9.97%Debt/Eq-Sales Q/Q4.30%SMA504.01%Rel Volume0.75Prev Close402.59
Employees320,000LT Debt/Eq-15.68EarningsOct 23SMA200-11.96%Avg Volume1.67MPrice406.61
IPO DateMar 10, 2011Option/ShortYes / YesEPS/Sales Surpr.0.40% 2.40%Net Debt/EBITDA3.02Volume1,255,579Change1.00%
Analyst Ratings
DateActionAnalystRatingTarget
Jul-28-26ReiteratedGoldman SachsBuy$520$485
Jul-27-26ReiteratedDeutsche BankBuy$540$476
Jul-27-26ReiteratedRobert W. Baird$396$393
Jul-27-26ReiteratedMorgan StanleyUnderweight$425$380
Jul-27-26ReiteratedUBSBuy$635$579
Jul-27-26ReiteratedBarclaysEqual Weight$402$387
Jul-27-26ReiteratedKeybancOverweight$510$435
Jul-27-26ReiteratedOppenheimerOutperform$520$485
Jul-20-26ReiteratedWells FargoEqual Weight$428$369
Jul-16-26ReiteratedBarclaysEqual Weight$427$402
Latest News
Jul-29-26
Jul-28-26
Jul-27-26
Jul-26-26
Jul-26-2602:02AM
Jul-24-26
Company

HCA Healthcare, Inc., operating through its subsidiaries, delivers a comprehensive array of healthcare services throughout the United States. The organization manages a network of general and acute care hospitals that provide a full spectrum of medical and surgical care, encompassing inpatient services, intensive care, cardiac treatment, diagnostic procedures, and emergency services. These hospitals additionally offer a broad range of outpatient care, such as ambulatory surgery, laboratory testing, radiology, respiratory therapy, cardiology, and physical therapy. Beyond its hospital infrastructure, HCA Healthcare operates numerous specialized outpatient facilities. These include standalone ambulatory surgery centers, dedicated emergency care facilities, urgent care clinics, walk-in clinics, advanced diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology treatment facilities, physician practices, and various other healthcare sites. Furthermore, the company oversees psychiatric hospitals, which offer diverse therapeutic programs. These services cater to child, adolescent, and adult psychiatric care, alongside adolescent and adult alcohol and drug abuse treatment and counseling. As of December 31, 2021, HCA Healthcare's extensive portfolio included 182 hospitals, specifically 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals. Its network also featured 125 freestanding surgery centers and 21 freestanding endoscopy centers, all distributed across 20 states and England. Founded in 1968 and formerly known as HCA Holdings, Inc., the company's corporate headquarters are situated in Nashville, Tennessee.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue78,01375,60070,60364,96860,23358,75251,53351,33646,677
Cost of Goods Sold Incl. D&A55,89244,22641,92539,38937,05636,2608,3698,4817,724
Gross Profit22,12131,37428,67825,57923,17722,49243,16442,85538,953
Selling, General and Administrative Excl. Other16,5737,99731,17029,48727,68526,77923,87423,56021,425
Research and Development
000000000
Other Operating Expense-6,52511,412-13,039-13,535-13,561-13,96512,02812,07710,886
Operating Income12,07311,96510,5479,6279,0539,6787,2627,2186,642
Interest Expense2,3162,2482,0611,9381,7391,5291,5601,8411,765
Unusual Expense
Non-Operating Income (Expense)11411537171,2661,684-272-133458
Net Income Before Taxes9,8719,8328,5237,7068,5809,8335,4305,2445,335
Income Taxes2,0182,0501,8661,6151,7462,1121,0431,099946
Consolidated Net Income6,8406,7845,7605,2425,6436,9563,7543,5053,787
Net Income From Continuing Operations7,8537,7826,6576,0916,8347,7214,3874,1454,389
Net Income6,8406,7845,7605,2425,6436,9563,7543,5053,787
EPS (Recurring)29.9628.6222.2719.2419.4421.5111.0810.2711.04
EPS (Basic, Before Extraordinaries)29.9628.6222.2719.2419.4421.5111.0810.2711.04
EPS (Diluted)29.8728.3822.0018.9619.1521.1610.9310.0710.66
EBITDA15,83515,60313,89612,72113,29014,2529,7359,6649,368
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio13.6116.4513.6414.2812.5312.1415.0514.6811.67
Price To Sales Ratio1.161.431.101.131.161.411.080.980.91
Gross Margin28.3641.5040.6239.3738.4838.2883.7683.4883.45
Operating Margin15.4815.8314.9414.8215.0316.4714.0914.0614.23
Net Margin8.778.978.168.079.3711.847.286.838.11
Shares Outstanding223231259272290323339341343
Market Capitalization90,674107,84577,73973,62569,58882,98555,75250,40342,686
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$576.75$508.24$439.72$371.21$302.70 Close Price0.00M7.32M14.64M21.96M29.28MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
McAlevey Michael REVP & Chief Legal & Admin Off.Feb 18 '26Sale533.371,694903,5378,853Feb 18
McAlevey Michael REVP & Chief Legal & Admin Off.Feb 13 '26Option Exercise236.615,0001,183,05013,853Feb 18
Berres JenniferSVP & Chief Human Res. OfficerFeb 11 '26Sale514.588,0204,126,95011,993Feb 12
Wyatt Christopher F.SVP & ControllerFeb 11 '26Sale505.004,0002,020,00044,379Feb 12
Wyatt Christopher F.SVP & ControllerFeb 05 '26Option Exercise139.0610,6701,483,77051,737Feb 09
Foster Jon MEVP and COOFeb 05 '26Option Exercise139.0629,3304,078,63029,330Feb 09
HAZEN SAMUEL NCEOFeb 03 '26Sale501.0442,87721,483,27532,276Feb 05
Cuffe Michael S.EVP and Chief Clinical OfficerFeb 03 '26Sale498.091,500747,13530,003Feb 05
HAZEN SAMUEL NCEOJan 30 '26Option Exercise81.9684,3606,914,146116,636Feb 02
McAlevey Michael REVP & Chief Legal & Admin Off.Nov 05 '25Sale473.793,8921,843,9913,487Nov 05
McAlevey Michael REVP & Chief Legal & Admin Off.Nov 03 '25Option Exercise236.6113,1703,116,15416,657Nov 05
HAZEN SAMUEL NCEOOct 31 '25Option Exercise69.5858,0504,039,11975,279Nov 04
Cuffe Michael S.EVP and Chief Clinical OfficerSep 08 '25Sale418.843,8361,606,67031,503Sep 08
Cuffe Michael S.EVP and Chief Clinical OfficerSep 04 '25Option Exercise173.1210,9201,890,47042,423Sep 08
Foster Jon MEVP and COOMay 13 '25Sale369.3215,6985,797,66112,646May 15
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.